Session date: 
11/21/2022 - 12:00pm to 1:00pm

Title:  Botulinum Toxin A (Botox) for Refractory Trigeminal Neuralgia

Learning Objectives
Upon conclusion of this activity, participants should be able to:

  • Introduce trigeminal neuralgia as a diagnosis, including a clinical case of refractory trigeminal neuralgia
  • Discuss first and second-line pharmaceutical options for treatment as well as procedural/surgical treatment for trigeminal neuralgia
  • Evaluate the available evidence for Botulinum Toxin A as an adjunct treatment for refractory trigeminal neuralgia
ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010image within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Christopher Anderson, M.D.
Where did the idea for the course originate?: 
Arizona
Please login or register to take this course.
Where did the idea for the course originate?: 
Arizona